JESUS JIMENEZ: Open Payments
NPI 1992757355 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 49 payments from 10 companies in 2025. Trend: 2023 $1,235 · 2024 $1,626 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $296 |
| Corium, LLC | 15 | $263 |
| Vanda Pharmaceuticals Inc. | 9 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $123 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| ABBVIE INC. | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
Products named: REXULTI, Azstarys, FANAPT, TRINTELLIX, Auvelity, CAPLYTA, VRAYLAR, ARISTADA.
Industry payments across TX — which companies pay providers there.
